HPV Specific Immunotherapy for Cervical Intraepithelial Neoplasia Using VGX-3100 Induces Regression of Cervical Lesions and Potent T Cell Responses: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study (VAC13P.1135)
The Journal of Immunology（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要